Upload
docong
View
214
Download
0
Embed Size (px)
Citation preview
Newsletter April 2014 Issue: II
Society of Ladies in Dermatology is an initiative to bring together lady dermatologists to
further academic interactions among our peers. The second meet of SOLID (Chennai) held
on March 9 th, 2014 was an interesting blend of academia and entertainment.
BOARD MEMBERS
President: Dr.S. Shobana MD, DD
Secretary: Dr. Samna Pramod, DDVL
ADVISORY BOARD
Dr. D. Prabhavathy MD, DD
Dr. K. N. Sarveshwari MD, DD, DNB
Dr. Maya Vedamurthy MD, DD
Dr. Parvathi Padmanabhan MD, DD
EDITORIAL BOARD
Dr. Shwetha Rahul MD.DVL
Dr. S. Varalakshmi DDVL
Dr. Sindhuja MD.DVL
EXECUTIVE BOARD
Dr.T.K. Anandi MD
Dr. Renuka Ramakrishnan MD
Dr. Vidya gives an insight into ‘Facial melanoses’ and
newer advances in their management
PRESIDENT’S MESSAGE:
Dear Ladies,
Greetings and Warm wishes to all members of SOLID!
The SOLID had its second meeting on March 9th 2014 to coincide with Women's Day
celebrations. Dr T. S.Vidya from Bengaluru shared her views on the practical management of
facial melanoses. The interactive session that followed was very lively and stimulating. We
were also addressed by Dr Nagabooshanam regarding issues in medical malpractice and how
to safeguard ourselves. M/s New India Assurance explained the various policies available for
doctors to insure themselves against litigation. An entertainment session followed which was
full of camaraderie and good natured ribbing. On the whole, it was a truly enjoyable session.
On a more serious note, it is common knowledge that most, if not all of us, suffer from the
"Sitting Disease". This condition affects all of those who spend long hours sitting in our cars,
consultation rooms as well as in front of the television. Sitting disease is known to make us
more prone to diabetes, hypertension, cardiac disease and obesity. To counter the ill effects of
prolonged sitting one needs to get NEAT - non-exercise activity thermogenesis. Would you like
to know more? Then ladies, welcome to the third meeting of SOLID!
With best wishes,
Dr Shobana S.
From the editor’S desk:
Dear colleagues,
We are two meetings old and we are already making a SOLID impact with
our e journal! We thank the contributors for the excerpts from the guest talks
and articles. However, we have a long journey ahead, rather an unending one, in
our pursuit of continuing medical education.
We urge and would appreciate a more active participation from members
with new ideas, articles, and clinical cases.
Warm regards,
Editorial Team
Facial Melanoses
Facial melanoses was the topic discussed elaborately by Dr. Vidya .T.S.
They are a complex group of diagnostic problems resulting from disruption of melanin cycle,
factors stimulating melanocytes and ultraviolet radiation. The following are the common
contributors to it:
I. Melasma: Face is the most commonly affected site and may extend to ‘V’ of neck.
According to the site (in the face) it could be,
Centro facial
Malar
Mandibular.
According to course it is classified into:
Transient type – disappears within a year of withdrawal of hormonal status.
Persistent type
II. Erythema dyschromicum perstans – Asymptomatic enlarging persistant macules of
variable size over face, trunk and limbs.
III. Lichen planus pigmentosus
IV. Riehl’s melanosis.
V. Erythrose peribuccale pigmentaire of Brocq
VI. Poikiloderma of Civatte.
VII. Erythromelanosis follicularis of face and neck.
VIII. Nevus of Ota.
IX. Periorbital melanosis.
X. Addison’s disease.
XI. Exogeneous Ochronosis.
XII. Post chikungunya pigmentation: Asymptomatic brownish black pigmentation
involving centrofacial area in the form of freckles like macules or slate colored
pigmentation.
XIII. Acanthosis nigricans.
Treatment:
a) Life style modification - Avoiding peak hours of sunlight.
b) Photo protection - Clothes and sunscreens (opaque sunscreen).
c) Avoiding provoking factors
d) Lightening agents – topical-hydroquinone – 2 to 4%, Azelaic acid 10 to 20%, Modified
kligman’s formula (Hydroquinone, tretinoin and fluocinolone acetonide) and kojic acid.
e) Chemical peeling: TCA, Jessners solution, alpha hydroxy acids, kojic acid and salicylic
acid.
f) Topical corticosteroids- can be tried for a short duration.
g) Lasers:
Combination of pulsed Co2 laser and alexandrite laser gives a better reduction in MASI.
Q switched alexandrite laser combined with TCA and jessners solution gives good to
excellent response.
Erbium YAG laser effective in women with melasma.
Q switched ruby laser is ineffective in melasma.
For melasma the consensus is that first line therapy should consist of effective topical
therapies mainly fixed triple combinations.
New therapeutic modalities:
1) Lactic acid peels for melasma.
2) 10% zinc sulphate solution for melasma.
Twice daily application for 2 months showed 50% improvement.
3) Rucinol serum for melasma.
Inhibits activity of both tyrosinase and TRP-1 involved in melanogenesis.
Applied twice daily for 3 months showed significant improvement with good tolerability
and acceptance.
4) N-acetylglucosamine and niacinamide
Inhibits melanin high stability and tolerance present.
5) Vitamin C with Vitamin E and ferrulic acid:-
Being a potent anti oxidant mixed with vitamin C & vitamin E, ferrulic acid gives added
photo protection.
Other agents which can be tried- Grape seed extract, polypodium, oat meal extract,
silymarin, tea tree.
Pediatric drugs and dosages commonly used in
dermatological practice
By Dr. Shwetha Rahul
ANTIBIOTICS
S.NO DRUG DOSAGE(mg/kg/da
y) DOSING SCHEDULE (DIVIDED DOSE)
1 Amoxicillin 20-50
8-12 hrly Cap 250,500,
Dispersable tab 125,250 mg
(BD/TDS)
Dry syrup125 mg/5ml,250mg/5ml;
Drops 100mg/ml;
Inj 250/500mg per vial
2 Amoxcillin-
Clavulanate 20-50 BD
Suspension 125+ 31.25,
Syp 200+ 28.5,
Tab 250+125,500+125
Inj 500+125mg, 1g+0.2g
3 Cephalexin 25-50 Q ID/BD
Cap-250,500
Tab-(DT)125,250
SYP-125mg/5ml
Drops-100mg/ml
4 Cefuroxime 15-30(oral)
50-100 (i.v) BD
Tab.125,250,500,
Suspension-125mg/5ml,
250mg/5ml, Injection-
250,750,1.5g/vial
5 Cefaclor 20 BD
CAP 250,500 mg DTab-
125,250mg
Syp 125mg/5ml, Drops 50mg/ml
6 Cefaperazone 100-150(IV) BD/TDS Inj 250 mg/500mg/1g/1.5g/2g
with sulbactum 0.5/1g
7 Cefotaxime 100-150(IV) TDS/QID Inj 125 mg, 250mg, 500mg,1g
8 Azithromycin
Day 1 :
10 mg/kg/day
Day 2-5 : 5mg/kg/d
OD
Kid Tab 100mg ;
Tab 250,500mg
Dry Syp 100,200mg/5ml
9
Doxycycline
(contraindicate
d in children
<8 yrs)
2 BD
Syp 25mg/5ml,
Drops 10mg/ml
Cap / disp tab 100mg
10 Erythromycin 30- 50 QID Susp / syp 100, 125 mg/ 5 ml
Drops 100mg/ml,Tab 250, 500 mg
11 Gentamycin 5-7.5 (IV) BD/TDS INJ 40 mg
12 Cotrimoxazole 6-12 mg
trimethoprim BD
Tab-80(T)+400(S) ,DS
Tab160+800
Syrup/susp 40mg trimethoprim
+ 200 mg sulfamethoxazole/ 5ml
13 Metronidazole 30mg/kg QID Tab 200 /300/400 mg
Syp/susp 200mg/5ml
14 Rifampicin 10-20 OD/BD Susp 100mg/5ml, 200 mg/ 5ml
Cap 150, 300,450, 600 mg
ANTIVIRAL DRUGS: S.NO DRUG DOSAGE Available as:
1. Acyclovir:
Varicella in
immunocompetent 20 mg /kg/dose QID for five days QID
Varicella in
immunocompromised
20mg/kg/dose i.v at a constant rate
over 1 hr TDS for seven days TDS
ANTI FUNGAL DRUGS:
S.NO DRUG DOSAGE(mg/kg/day) Can be given from the
age of:
1 Griseofulvin
10-20mg/kg
(In 2 divided doses)
4 mnths
2 Fluconazole 3 mg/kg/day Birth
3 Itraconazole 5mg/kg/day 6 mnths
4 Ketoconazole 3-6mg/day 2 yrs
5 Terbinafine 5mg/kg/day 2 yrs
6 Amphotericin- B 0.5-1mg/kg/day
ANTISCABETIC DRUG:
S.N
O DRUG DOSAGE(mg/kg/day)
DOSING SCHEDULE
(DIVIDED DOSE)
1 Ivermectin 0.2mg/kg/day Tab- 3, 6,12 mg, susp -1.5/3 mg +
400/200mg albendazole
ANTIHISTAMINICS: S.NO DRUG DOSAGE(mg/kg) DOSING SCHEDULE / Available as:
1. Diphenhydramine 5mg/ kg /day
TDS/QID
(divided dose)
Syp 12.5mg/5ml
Cap 25mg, 50 mg
2.
Chlorpheniramine
maleate
3-5 mths: 0.5 mg BD
6-18 mnths: 1-1.5 mg
BD/TDS
2-5 yr: 1mg BD/TDS
Injectable:
0.35 mg/kg/day in
divided doses 4-6
hrly
Syp 2mg/ 5ml
Tab 4 mg
Inj 10mg/ml
3
Dexchlorpheniramine
maleate
2-5yr: 0.5mg/dose
6-11 yr: 1mg/dose
TDS Syp 2mg/5ml, Tab 2
mg
4
Hydroxyzine 2mg/kg/day TDS/QID
(divided dose)
Syp 10mg/5ml
drop 6mg/ml
Tab- 10 mg, 25mg
Inj 25mg/ml
5
Cetrizine
2-5yrs-2.5mg/dose
>6yrs -5-10mg/dose
OD Syp 5mg/5ml,
Tab 5,10 mg
6
Loratidine 2-5yrs-5mg
>6yrs-10mg OD
Syp 1mg/ml, 5mg/5ml
Tab-10 mg
7
Montelukast
( To avoid in child<2
yrs)
2-5yrs- 4mg
6-14yrs- 5mg HS Tab-4,5,10mg
ANTI-INFLAMMATORY DRUGS:
S.N
O DRUG
DOSAGE
(mg/kg/day)
DOSING SCHEDULE /AVAILABLE
AS:
(DIVIDED DOSE)
1 Prednisolone. 0.5-2 OD/BD
Tab 5,10,20,30,40 mg, syp
15mg/5ml
2 Paracetamol 30-60
TDS/QI
D
Syp 125mg/5ml,
Drops:30mg/ml
drops:30mg/ml
IMMUNOSUPPRESSANTS:
S.NO DRUG DOSAGE(mg/kg/day) DOSING SCHEDULE (DIVIDED
DOSE)
1 Cyclosporine 3-5mg/kg/day In two divided dose
2 Azathioprine 1-2.5mg/kg/day
3 Methotrexate 0.2-0.4mg/kg/week In single or divided dose
MISCELLANEOUS:
S.NO DRUG DOSAGE(mg/kg/day) DOSING SCHEDULE
/AVAILABLE AS
1 Zinc 0.5-1mg/kg/day 1-3 divided doses
2 Vit- A
<1 yrs: 100,000 u every 4-6
months
>1 yrs: 200,000 u every 4-6
months
Available as Inj 1lakh IU/2ml
Drops 1.5 lakh IU/ml
>8yrs:1-3 days 1lakhs u/day
4-14 days 50000 u /day
3
Calcium
supplementation
Neonate: 50-150mg/kg/24 hrs
Child: 45-65mg/kg/24 hrs Available as syp 250mg/5ml
4 Omeprazole
0.5-1mg/kg/dose OD or BD
5-10kg- 5mg OD
10-20kg- 10mg OD
More than 20 kg- 20mg OD
Available as Cap 20/40mg.
2mg/ml solution
5 Ranitidine
4-10mg/kg/day,
Divided dose 8-12 hrs
Tab 150,300mg
Inj 25mg/ml
REGISTRATION DETAILS: Eligibility criteria : MD, DD Dermatology
MD, DDVL, DNB Dermatology, Venereology and Leprosy
Registration fees : Nil
The registration form is attached separately. The filled registration form along
with a copy of the required certificates (undergraduate, postgraduate degree and
registration certificates) and one passport size photograph needs to be mailed to the
following address:
Dr. Samna Pramod
2A Ramkamal flats, No. 18, Sivaganga Road, Nungambakkam, Chennai 600034
Ph: 044 28267719
You can e mail your articles / case presentations to:
[email protected], [email protected]
Or contact: Dr. Varalakshmi {9444140971} Dr. Sindhuja{9840457041}